admin

13th International Pharma Convention 2025

The 13th International Pharma Convention 2025 brings together industry leaders, innovators, and experts to discuss the future of Pakistan’s pharmaceutical industry, focusing on compliance, capacity, and global connectivity. 𝐆𝐮𝐞𝐬𝐭𝐬 𝐨𝐟 𝐇𝐨𝐧𝐨𝐫: Mr. Muhammad Kamran Nasir – Sr. Vice Chairman PPMAMr. Athar Nazir Sheikh – Vice Chairman PPMAMr. Mutti ur Rehman – Chairman South Zone, PPMA […]

13th International Pharma Convention 2025 Read More »

National Pharma Dialogue: Charting the Future of Growth & Exports

At TDAP’s National Pharma Stakeholders Dialogue, industry leaders, regulators, and investors came together to discuss the way forward. Kamran Nasir, Senior Vice Chairman PPMA, emphasized the need for policy reforms, addressing API duty issues, and establishing WHO-standard labs to boost exports and strengthen Pakistan’s pharmaceutical sector. A stronger, globally competitive pharma industry starts with the right reforms.

National Pharma Dialogue: Charting the Future of Growth & Exports Read More »

PPMA Leadership Panel Discussion at the Pharma Innovation Summit 2025

Topic: Strengthening Export Competitiveness Building Pakistan’s Global Pharma, Biologicals & Patent Portfolio Footprint. 𝐌𝐨𝐝𝐞𝐫𝐚𝐭𝐨𝐫: 𝐏𝐚𝐧𝐞𝐥𝐢𝐬𝐭𝐬: The panel highlighted Pakistan’s pathway toward a stronger global presence through innovation, technology-driven manufacturing, and enhanced export competitiveness.

PPMA Leadership Panel Discussion at the Pharma Innovation Summit 2025 Read More »

Driving Pharma Forward Through Technology, Innovation & Global Competitiveness.

𝐒𝐫. 𝐕𝐢𝐜𝐞 𝐂𝐡𝐚𝐢𝐫𝐦𝐚𝐧 𝐏𝐏𝐌𝐀 𝐌𝐫. 𝐊𝐚𝐦𝐫𝐚𝐧 𝐍𝐚𝐬𝐢𝐫 addressed the participants of the 𝐏𝐡𝐚𝐫𝐦𝐚 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟓 𝐨𝐧 𝟏𝟗𝐭𝐡 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 at 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐀𝐫𝐞𝐧𝐚, 𝐓𝐮𝐥𝐢𝐩 𝐌𝐚𝐫𝐪𝐮𝐞𝐞, 𝐈𝐬𝐥𝐚𝐦𝐚𝐛𝐚𝐝.He highlighted how Pakistan’s pharmaceutical industry can transition toward technology-driven manufacturing, export competitiveness, and innovation-led growth, alongside industry leaders, regulators, and innovators shaping the nation’s pharma future.

Driving Pharma Forward Through Technology, Innovation & Global Competitiveness. Read More »